William van Osdol
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiopharmaceutical Chemistry and Applications 1
-
- Protein purification and stability 4
- Co-authors
- John N. Weinstein (5 shared papers)Ronald D. Neumann (1 shared paper)Miguel Pérez-Bacete (1 shared paper)Chang H. Paik (1 shared paper)Jun Sato (1 shared paper)Malik E. Juweid (1 shared paper)Kenji Fujimori (1 shared paper)Kenneth D. Paull (1 shared paper)
- Journals
- Regulatory Toxicology and Pharmacology (1 paper)Stem Cells (1 paper)International Journal of Immunopharmacology (1 paper)PubMed (3 papers)Advances in Bioengineering (1 paper)
- Partner nations
- United States
In The Last Decade
William van Osdol
7 papers receiving 631 citations
Peers
Comparison fields: 5 of 71
- Radiology, Nuclear Medicine and Imaging 324
- Biomaterials 138
- Oncology 164
- Immunology 90
- Molecular Biology 285
Countries citing papers authored by William van Osdol
This map shows the geographic impact of William van Osdol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William van Osdol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William van Osdol more than expected).
Fields of papers citing papers by William van Osdol
This network shows the impact of papers produced by William van Osdol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William van Osdol. The network helps show where William van Osdol may publish in the future.
Co-authors
The 25 scholars most cited alongside William van Osdol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. | 1992 | 335 |
| 2 | An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier". | 1991 | 139 |
| 3 | Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the "binding site barrier". | 1992 | 88 |
| 4 | 1994 | 55 | |
| 5 | 1992 | 26 | |
| 6 | 2022 | 3 | |
| 7 | 1998 | 1 |
About William van Osdol
William van Osdol is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, Organic Chemistry and Pharmacology, having authored 7 papers that have together received 647 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Protein purification and stability (4 papers), Advanced Proteomics Techniques and Applications (1 paper), Computational Drug Discovery Methods (1 paper), Advancements in Transdermal Drug Delivery (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Antimicrobial agents and applications (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (324 citations), Biomaterials (138 citations), Oncology (164 citations), Immunology (90 citations) and Molecular Biology (285 citations). William van Osdol has collaborated with scholars based in United States. Frequent co-authors include John N. Weinstein, Ronald D. Neumann, Miguel Pérez-Bacete, Chang H. Paik, Jun Sato, Malik E. Juweid, Kenji Fujimori, Kenneth D. Paull, John K. Buolamwini and Larry Rubinstein. Their work appears in journals such as Regulatory Toxicology and Pharmacology, Stem Cells, International Journal of Immunopharmacology, PubMed and Advances in Bioengineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.